WORLD’S LARGEST STUDY IN INTRAVENOUS CATHETER SECUREMENT FOR CHILDREN AND CATHETER FAILURE REDUCTION
Brooke Charters, Paediatric Emergency Nurse
Gold Coast Hospital and Health Service
PEOPLE IN HEALTH CARE
Filmed in Southport, Queensland | December 2024
Brooke Charters is a dynamic Paediatric Emergency Nurse who works at the Gold Coast University Hospital in Queensland.
After leaving school unsure of her career path, she ventured into disability support, which sparked her interest in nursing. She pursued a Bachelor of Nursing at Southern Cross University, and during her placement in Africa, she discovered her passion for paediatrics instead of mental health nursing.
Since completing her post grad certificate in paediatric acute care and a passion ignited from working frontline in the Paediatric Emergency, Brooke has developed a wide variety of clinical research interests, especially in cannulation, children’s mental health trauma and pain management.
An opportunity arose when she was approached for research ideas related to securing cannulas, a frequent issue in paediatric care.
Brooke was the first nurse to become a Principal Investigator on an Emergency Medicine Foundation (EMF) Queensland Research Program grant when it was opened to nurses. Having seen first-hand how one in four cannulas used in treating children were failing
and needed to be reinserted Brooke looked for an opportunity to find a solution.
The study enrolled children aged six months to eight years, aiming to save cannulas and reduce reinsertion trauma. Her study’s findings showed significant improvements in securing cannulas, highlighting a potential solution to a common problem.
Brooke initiated a study with a randomised control trial (RCT) comparing standard care to an integrated dressing with tissue adhesive.
Brooke’s research became the world’s largest study of its kind and in May 2024 the results of the study were published in JAMA Pediatrics. Her mission is to drive change and enhance the hospital experience for children globally.
-
Nuclear medicine funding a win for men with prostate cancer
Australian men with higher risk prostate cancer now have access to a nuclear medicine scan to help detect and treat metastatic disease, after it was listed on the Medical Benefits Schedule (MBS) from 1st July 2022.
In 2021 over 18,000 Australian men were diagnosed with prostate cancer, resulting in over 3,000 lives being lost – and making prostate cancer Australia’s second most common cause of cancer death in men.
Australian Health Journal spoke with AANMS President Associate Professor Sze Ting Lee and Dr Geoff Schembri on the MBS listing and the efforts to get it listed.
-
WA and QLD RSV Immunisation programs show drops in infant hospitalisations
RSV is the number one cause of hospitalisation of Australian children under five years of age, according to the Immunisation Foundation of Australia (IFA). There are mounting concerns that Australians at greatest risk of severe Respiratory Syncytial Virus, or RSV will miss out on protection against the lung infection, with the Federal Government failing to commit to a national RSV immunisation program.
-
Priming Australia for social prescribing
Social prescribing provides support in various areas of people’s lives, leading to increased confidence, improved navigation of systems, and enhanced friendships and trust in healthcare, while communities should be designed in an age-friendly way to prevent isolation.
In Part 1 of the Models of Care on Social Prescribing, Australian Health Journal spoke to 4 people advocating for social prescribing in Australia
